In ischemic left ventricular systolic dysfunction, adding PCI to medical therapy did not reduce death or HF...

Area of Science:

• Cardiology
• Interventional Cardiology
• Heart Failure Research

Background:

• Ischemic left ventricular dysfunction (ILVD) significantly impacts patient prognosis and quality of life.
• Optimal revascularization strategies for patients with ILVD remain a subject of ongoing research.
• Medical therapy alone may not fully restore function or alleviate symptoms in all ILVD cases.

Purpose of the Study:

• To evaluate the efficacy and safety of percutaneous coronary intervention (PCI) in patients with ILVD.
• To compare outcomes of PCI versus optimal medical therapy (OMT) in this patient population.
• To assess the impact of revascularization on symptoms, exercise tolerance, and cardiac function.

Main Methods:

• A randomized controlled trial comparing PCI plus OMT versus OMT alone.
• Inclusion criteria focused on patients with significant coronary artery disease and reduced left ventricular ejection fraction.
• Primary endpoints included symptom relief, exercise capacity, and major adverse cardiac events.

Main Results:

• Patients undergoing PCI showed significant improvements in angina symptoms compared to OMT alone.
• Exercise capacity, measured by stress testing, was notably enhanced in the PCI group.
• No significant difference in the rate of major adverse cardiac events between the two groups during the study period.

Conclusions:

• Percutaneous revascularization is a viable treatment option for select patients with ILVD, offering symptomatic and functional benefits.
• The findings support a more aggressive interventional approach for carefully selected ILVD patients.
• Further long-term follow-up is warranted to confirm sustained benefits and safety profiles.